A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis

Statistics in Medicine

Volumn 30, Issue 12, 2011, Pages 1419-1428

  Tervonen, Tommi ^a   van Valkenhoef, Gert ^b,c   Buskens, Erik ^c   Hillege, Hans L ^c   Postmus, Douwe ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Benefit risk analysis; Clinical pharmacology; Decision analysis; Stochastic multi criteria accept ability analysis (SMAA)

Indexed keywords

FLUOXETINE; PLACEBO; VENLAFAXINE;

ADVERSE DRUG REACTION; ANXIETY; ARTICLE; CALCULATION; DATA ANALYSIS; DECISION MAKING; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RISK BENEFIT ANALYSIS; HUMAN; INCIDENCE; INSOMNIA; MEDICAL DECISION MAKING; NAUSEA; PROBABILITY; RANK ACCEPTABILITY INDEX; RATING SCALE; RISK BENEFIT ANALYSIS; SIDE EFFECT; STOCHASTIC MODEL; STOCHASTIC MULTICRITERIA ACCEPTABILITY ANALYSIS;

ANTIDEPRESSIVE AGENTS; DECISION MAKING; DEPRESSION; HUMANS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; STOCHASTIC PROCESSES;

EID: 79955877878     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4194     Document Type: Article

References (31)

1. McGregor M, Caro JJ. QALYs: are they helpful to decision makers? Pharmacoeconomics 2006; 24(10):947-952.
2. Claycamp HG. Rapid benefit-risk assessment: no escape from expert judgments in risk management. Risk Analysis 2006; 26(1):147-156.
3. Garrison Jr LP, Towse A, Bresnahan BW. Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis. Health Affairs 2007; 26(3):684-695.
4. Mussen F, Salek S, Walker S. A quantitative approach to benefit-risk assessment of medicines-part 1: the development of a new model using multi-criteria decision analysis. Pharmacoepidemiology and Drug Safety 2007; 16(Suppl. I):S12-S15.
5. Tervonen T, Figueira JR. A survey on stochastic multicriteria acceptability analysis methods. Journal of Multi-Criteria Decision Analysis 2008; 15(1-2):1-14. DOI: 10.1002/mcda.407.
6. Felli JC, Noel RA, Cavazzoni PA. A multiattribute model for evaluating the benefit-risk profiles of treatment alternatives. Medical Decision Making 2009; 29(1):104-115.
7. Lahdelma R, Hokkanen J, Salminen P. SMAA-stochastic multiobjective acceptability analysis. European Journal of Operational Research 1998; 106(1):137-143. DOI: 10.1016/S0377-2217(97)00163-X.
8. Lahdelma R, Salminen P. SMAA-2: stochastic multicriteria acceptability analysis for group decision making. Operations Research 2001; 49(3):444-454. DOI: 10.1287/opre.49.3.444.11220.
9. Tervonen T, Linkov I, Steevens J, Chappell M, Figueira JR, Merad M. Risk-based classification system of nanomaterials. Journal of Nanoparticle Research 2009; 11(4):757-766. DOI: 10.1007/s11051-008-9546-1.
10. Tervonen T, Figueira JR, Lahdelma R, Almeida Dias J, Salminen P. A stochastic method for robustness analysis in sorting problems. European Journal of Operational Research 2009; 192(1):236-242. DOI: 10.1016/j.ejor.2007.09.008.
11. Hokkanen J, Lahdelma R, Salminen P. A multiple criteria decision model for analyzing and choosing among different development patterns for the Helsinki cargo harbor. Socio-Economic Planning Sciences 1999; 33:1-23.
12. Tervonen T, Hakonen H, Lahdelma R. Elevator planning with stochastic multicriteria acceptability analysis. Omega 2008; 36(3):352-362. DOI: 10.1016/j.omega.2006.04.017.
13. Kangas A, Kangas J, Lahdelma R, Salminen P. Using SMAA-2 method with dependent uncertainties for strategic forest planning. Forest Policy and Economics 2006; 9:113-125. DOI: 10.1016/j.forpol.2005.03.012.
14. Kangas J, Hokkanen J, Kangas A, Lahdelma R, Salminen P. Applying stochastic multicriteria acceptability analysis to forest ecosystem management with both cardinal and ordinal criteria. Forest Science 2003; 49(6):928-937.
15. Hokkanen J, Lahdelma R, Miettinen K, Salminen P. Determining the implementation order of a general plan by using a multicriteria method. Journal of Multi-Criteria Decision Analysis 1998; 7(5):273-284. DOI: 10.1002/(SICI)1099-1360(199809)7:5 <273::AID-MCDA198 >3.0.CO;2-1.
16. Kangas J, Kangas A. Multicriteria approval and SMAA-O method in natural resources decision analysis with both ordinal and cardinal criteria. Journal of Multi-Criteria Decision Analysis 2003; 12(1):3-15. DOI: 10.1002/mcda.344.
17. Lahdelma R, Salminen P, Hokkanen J. Locating a waste treatment facility by using stochastic multicriteria acceptability analysis with ordinal criteria. European Journal of Operational Research 2002; 142(2):345-356. DOI: 10.1016/S0377-2217(01)00303-4.
18. Nemeroff CB, Thase ME. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. Journal of Psychiatric Research 2007; 41:351-359.
19. Keeney R, Raiffa H. Decisions with Multiple Objectives: Preferences and Value Tradeoffs. Wiley: New York, 1976.
20. von Nitzch R, Weber M. The effect of attribute ranges on weights in multiattribute utility measurement. Management Science 1993; 39:937-943.
21. Tervonen T, Lahdelma R. Implementing stochastic multicriteria acceptability analysis. European Journal of Operational Research 2007; 178(2):500-513. DOI: 10.1016/j.ejor.2005.12.037.
22. Lahdelma R, Salminen P. Classifying efficient alternatives in SMAA using cross confidence factors. European Journal of Operational Research 2006; 170(1):228-240. DOI: 10.1016/j.ejor.2004.07.039.
23. Temple R, Ellenberg S. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Annals of Internal Medicine 2000; 133(6):455.
24. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression. Journal of the American Medical Association 2002; 287(14):1840-1847. DOI: 10.1001/jama.287.14.1840.
25. Belton V, Stewart TJ. Multiple Criteria Decision Analysis-An Integrated Approach. Kluwer Academic Publishers: Dordrecht, 2002.
26. Tervonen T. JSMAA an open source software for SMAA computations. In Proceedings of the 25th Mini-EURO Conference on Uncertainty and Robustness in Planning and Decision Making (URPDM2010), Coimbra, Portugal, Henggeler Antunes C, Rios Insua D, Dias L (eds), 2010.
27. Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey T. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Annals of Internal Medicine 2005; 143(6):415-426.
28. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet 2009; 373(9665):746-758. DOI: 10.1016/S0140-6736(09)60046-5.
29. Phillips LD. Decision conferencing. In Advances in Decision Analysis: From Foundations to Applications, Edwards W, Miles Jr R, von Winterfeldt D (eds). Cambridge University Press: Cambridge, 2007.
30. Salanti G, Higgins JPT, Ades AE, Ioannidis JPA. Evaluation of networks of randomized trials. Statistical Methods in Medical Research 2008; 17(3):279-301. DOI: 10.1177/0962280207080643.
31. Sutton AJ, Higgins JPT. Recent developments in meta-analysis. Statistics in Medicine 2008; 27(5):625-650. DOI: 10.1002/sim.2934.